Inactive Instrument

News Immunovant, Inc. Nasdaq

Equities

US45258J2015

Summary

Unlock all the news: Be the first to know and act before the market!

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	05-30	MT
Immunovant Q4 Loss Widens -- Shares Fall After-Hours	05-29	MT
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024	05-29	AQ
Immunovant, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	05-29	CI
Immunovant, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-29	CI
Immunovant Insider Sold Shares Worth $479,233, According to a Recent SEC Filing	05-24	MT
Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing	04-19	MT
Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing	04-19	MT
Oppenheimer Initiates Coverage on Immunovant With Outperform Rating, $50 Price Target	03-28	MT
Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target	03-13	MT
Immunovant Awarded U.S. Patent for IMVT-1402	03-12	AQ
Immunovant Insider Sold Shares Worth $486,362, According to a Recent SEC Filing	02-23	MT
JPMorgan Starts Coverage on Immunovant With Overweight Rating, $51 Price Target	02-20	MT
Wolfe Research Starts Immunovant With Outperform Rating, $55 Price Target	02-15	MT
Immunovant Posts Narrower Fiscal Q3 Loss	02-12	MT
Immunovant, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023	02-12	AQ
North American Morning Briefing : Stock Futures -2-	02-09	DJ
North American Morning Briefing : Jobs Report Tops -2-	02-02	DJ
Immunovant Insider Sold Shares Worth $383,012, According to a Recent SEC Filing	01-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Immunovant, Inc. Nasdaq

Equities

US45258J2015

Summary

Filters